Walk for Hope 2012

Walk for Hope 2012

Thank you for everybody who supported this event !!!!

Scent of Lavender has joined Walk for Hope to put an end to woman's cancers, because I want to make a difference in the fight against woman's cancers. More than 275,000 women will be diagnosed with breast or a gynecological cancer this year. More than 25% of those women will die from these diseases. I want to save these women. I want to help City of Hope researchers find cures.

October in this year was my 5th year of been breast cancer survivor. I am so grateful. I am so healthy and happy everyday..

City of hope saved my life and continually helping others. Thank you very much who walked with me also who donated money in this hard economical time. You will save more woman's life.

Walk for hope 2012 med

2012.11.06 | | Comments(0) | Trackbacks(0) | Breast Cancer

Aromasin cuts breast cancer risk 65 pct in some high-risk population

アロマターゼ阻害剤の効果 リサーチ

アロマターゼ阻害剤 で乳癌の再発率を65%低下のニュース

一度乳癌になると再発がとても心配です。 ホルモン性の原因でのガンタイプの人(女性ホルモンががん細胞の発生にに貢献しているガンで、更年期時に発見される乳癌はほとんどこのタイプです。)再発を防ぐために、更年期前の人は約5年Tamoxfen、更年期後はアロマターゼ阻害剤を医師からしょほうされます。


以下 研究に関する記事です。


2011-06-06 - 乳癌リスクが高い閉経後女性が参加したプラセボ対照大規模試験(NCIC CTG MAP.3試験)の僅か3年の追跡調査でアロマターゼ阻害剤エキセメスタン(exemestane)の有意な浸潤性乳癌抑制効果が示されました。


Aromasin cuts risk of breast cancer in some groups
* Cuts breast cancer risk 65 pct in high-risk population

* Pfizer drug now available as generic, cost has dropped

By Debra Sherman

CHICAGO, June 4 (Reuters) - Pfizer Inc's (PFE.N) breast cancer drug Aromasin, now available in a generic version, reduced the risk of developing the cancer by 65 percent in post-menopausal women, researchers said on Saturday.

A late-stage trial of 4,560 post-menopausal women who were at increased risk of developing breast cancer found that those who took the drug, also known as exemestane, had fewer invasive breast cancers after 3 years and without severe side effects.

"We are delighted with this two-thirds reduction," Dr. Paul Goss, director of Breast Cancer Research at Massachusetts General Hospital, said in a telephone interview.

He noted that there were fewer of the more aggressive types of tumors in patients who took the drug, but the limitation of the study was that the median follow-up was just 3 years.

The results were presented in Chicago at the annual meeting of the American Society of Clinical Oncology.

An estimated 1.3 million women are diagnosed with breast cancer worldwide each year and nearly 500,000 die of the disease.

The study broke participants up into two groups: One got the drug and the other got a placebo. There were 11 invasive breast cancers reported in the drug group compared with 32 in the placebo group. There were also fewer cases of precursor lesions in the group that got exemestane.

Goss, who led the study, noted that tamoxifen has been used for years to prevent breast cancer, but had serious side effects, including raising the risk of developing uterine cancer, cataract formations and stroke.


Exemestane did not cause high levels of toxicity, he said. Its side effects were much milder that those seen with tamoxifen, he said, although there was a slight increase in osteopenia -- low bone density, but not low enough to be classified as osteoporosis.

Other side effects reported in the study included hot flashes, sweating, fatigue, and insomnia.

"Age is the single biggest risk factor for developing breast cancer. Once you are 60, your risk increases so this (research) merits consideration for prevention. What we don't know is whether patients need to take this pill for life."

After 5 years, there was no dangerous accumulation of toxicity from the drug, he said.

"I can't look someone in the eye and swear it won't be (toxic over a longer period of time), but there's large evidence that the drug is safe," Goss said.

People have been taking statins to lower cholesterol and antihypertensive medications to reduce blood pressure for years, Goss noted. "This is the same concept."

And the price of exemestane has fallen significantly.

The drug, which lost its patent protection on April 1, 2011, generated sales of $483 million for Pfizer in 2010.

Commercially, even with its patent still protected, Aromasin was only a moderate seller in first quarter, with sales down 11 pct to $114 million.

The once-a-day oral tablet was originally approved to treat advanced breast cancer in post-menopausal women who had already been treated with tamoxifen for 2 to 3 years. The drug is also used to treat women whose breast cancer worsened while they were taking tamoxifen.

The drug is a hormone therapy classified as an "aromatase inhibitor," which work by decreasing the amount of estrogen the body produces. Lower estrogen levels can slow or even stop the growth of some breast tumors that need estrogen to grow.

(Reporting by Debra Sherman, Editing by Sandra Maler)

2011.06.17 | | Comments(1) | Trackbacks(0) | Breast Cancer

www.myboobiecancer.com ( breast cancer website)

Hello Scent of Lavender Customers,

pink  ribon

We are very proud to announce that we have established an affiliated website on breast cancer. We would like to develop it as a website that supports women with breast cancer. Cancer survivor or their supporters, all have impressive story. If you would like to share your own story with cancer or that of someone you know, please submit it to us. It will help and cheer other women.



My story (Mayumi diagnosed at 49)

In the summer of 2007, I was diagnosed with breast cancer just when I thought I had everything going right in my life. I had a mammogram exam after skipping it for 2 years having been so busy. The doctor found a lump on my left breast.

I was referred to the City of Hope which is well known for its remarkable treatment and research in cancer.

I was very comfortable with the medical staff at the “Women’s Health Center” which exclusively focuses on women’s health at City of Hope.

(If you would like to read more, please click site below:)


2011.02.28 | | Comments(0) | Trackbacks(0) | Breast Cancer

Thank you for your support

Dear Friend,

We would like to thank you for your support of the "Walk for Hope" event to help the City of Hope.

Scent of Lavender has raised a total donation of $340 this year.

We had six walkers at the event last Sunday .

The event was filled with a lot of positive energy to fuel the fight against breast cancer..

We appreciate your continuous support of City of Hope for breast cancer reserch. We believe that it is a great cause for all woman in the world.

Please see some photos below

walk for hope 2010
walk for hope 2010

Best regard

Mayumi Onami

Scent of Lavender

2010.11.18 | | Comments(0) | Trackbacks(0) | Breast Cancer

Walk for Hoe 5K 2010

Hello My Friend,

It's already been three years since I was diagnosed with breast cancer. Now I am cancer-free and enjoying my life with a healthy body.

This year I've registered for City of Hope's Walk for Hope on November 7, 2010 in Duarte, CA.
Walk for Hope supports women's cancer research, treatment and education at City of Hope, an amazing place that saves lives everyday. I want to help City of Hope find a way to eradicate cancer from our lives, so that one day we will be freed from this horrible disease. I know you feel the same way.

I have walked at this event before with my friends and had so much fun. It felt wonderful to do something for a great cause.
Walking 5K is easy and great exercise to do on a Sunday morning. Let's walk together.

If you would like to join me, please register your name at the site below.
It costs $25, and you can make an additional donation as well.

When you go to the site, click Los Angeles as the location and indicate "Scent of Lavender" as your team.


walk 2008


2010.10.01 | | Comments(0) | Trackbacks(0) | Breast Cancer

«  | HOME |  »